Several studies have confirmed the clinical beneficial of ACE inhibitors (ACEIs) and/or AT1R blockers (ARBs) in RA experimental animal models, including AIA and collagen-induced arthritis 6–9. The gene discussed is ACE; the disease is rheumatoid arthritis.